10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: MARCH 31, 2024

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 1-33145

SALLY BEAUTY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	36-2257936
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
3001 Colorado Boulevard
Denton, Texas	76210
(Address of principal executive offices)	(Zip Code)

(940) 898-7500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.01 par value	SBH	The New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐
Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of shares of common stock outstanding as of May 3, 2024: 103,514,140

TABLE OF CONTENTS

	Page
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements	4
Condensed Consolidated Balance Sheets	4
Condensed Consolidated Statements of Earnings	5
Condensed Consolidated Statements of Comprehensive Income	6
Condensed Consolidated Statements of Stockholders’ Equity	7
Condensed Consolidated Statements of Cash Flows	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3. Quantitative and Qualitative Disclosures About Market Risk	24
Item 4. Controls and Procedures	24
PART II — OTHER INFORMATION
Item 1. Legal Proceedings	25
Item 1A. Risk Factors	25
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.	25
Item 5. Other Information	25
Item 6. Exhibits	26

2

In this Quarterly Report, references to “the Company,” “Sally Beauty,” “our company,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would” or similar expressions may also identify such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

3

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except par value data)

	March 31, 2024			September 30, 2023
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	97,174		$	123,001
Trade accounts receivable, net		34,693			33,421
Accounts receivable, other		52,868			42,454
Inventory		1,039,752			975,218
Other current assets		55,836			53,903
Total current assets		1,280,323			1,227,997
Property and equipment, net of accumulated depreciation of $833,581 at    March 31, 2024, and $780,212 at September 30, 2023		273,175			297,779
Operating lease assets		562,770			570,657
Goodwill		534,494			533,081
Intangible assets, excluding goodwill, net of accumulated amortization of    $31,821 at March 31, 2024, and $30,587 at September 30, 2023		54,088			55,171
Other assets		41,692			40,565
Total assets	$	2,746,542		$	2,725,250
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	66,164		$	4,173
Accounts payable		289,606			258,884
Accrued liabilities		150,002			163,366
Current operating lease liabilities		137,631			150,479
Income taxes payable		366			2,355
Total current liabilities		643,769			579,257
Long-term debt		978,360			1,065,811
Long-term operating lease liabilities		458,030			455,071
Other liabilities		21,626			23,139
Deferred income tax liabilities, net		93,907			93,224
Total liabilities		2,195,692			2,216,502
Stockholders’ equity:
Common stock, $0.01 par value. Authorized 500,000 shares; 103,514 and    106,266 shares issued and shares outstanding at March 31, 2024, and    September 30, 2023, respectively		1,035			1,063
Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued		—			—
Additional paid-in capital		—			5,677
Accumulated earnings		666,647			624,772
Accumulated other comprehensive loss, net of tax		(116,832	)		(122,764	)
Total stockholders’ equity		550,850			508,748
Total liabilities and stockholders’ equity	$	2,746,542		$	2,725,250

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Earnings

(In thousands, except per share data)

(Unaudited)

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024			2023
Net sales	$	908,361	$	918,712	$	1,839,663		$	1,875,767
Cost of goods sold		445,289		450,373		909,415			918,854
Gross profit		463,072		468,339		930,248			956,913
Selling, general and administrative expenses		403,435		389,657		801,573			781,237
Restructuring		63		7,274		(22	)		17,680
Operating earnings		59,574		71,408		128,697			157,996
Interest expense		20,523		16,685		37,837			34,608
Earnings before provision for income taxes		39,051		54,723		90,860			123,388
Provision for income taxes		9,807		13,862		23,226			32,190
Net earnings	$	29,244	$	40,861	$	67,634		$	91,198
Earnings per share:
Basic	$	0.28	$	0.38	$	0.64		$	0.85
Diluted	$	0.27	$	0.37	$	0.63		$	0.83
Weighted-average shares:
Basic		104,276		107,453		105,117			107,294
Diluted		107,080		109,706		107,881			109,499

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

	Three Months Ended						Six Months Ended
	March 31,						March 31,
	2024			2023			2024			2023
Net earnings	$	29,244		$	40,861		$	67,634		$	91,198
Other comprehensive income (loss):
Foreign currency translation adjustments		(6,928	)		9,445			7,449			35,386
Interest rate swap, net of tax		1,584			—			(1,504	)		—
Interest rate caps, net of tax		—			(2,163	)		—			(1,960	)
Foreign exchange contracts, net of tax		468			(1,017	)		(13	)		(1,927	)
Other comprehensive income (loss), net of tax		(4,876	)		6,265			5,932			31,499
Total comprehensive income	$	24,368		$	47,126		$	73,566		$	122,697

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands)

(Unaudited)

													Accumulated
							Additional						Other			Total
	Common Stock						Paid-in			Accumulated			Comprehensive			Stockholders’
	Shares			Amount			Capital			Earnings			Loss			Equity
Balance at September 30, 2023		106,266		$	1,063		$	5,677		$	624,772		$	(122,764	)	$	508,748
Net earnings		—			—			—			38,390			—			38,390
Other comprehensive income		—			—			—			—			10,808			10,808
Share-based compensation		—			—			5,118			—			—			5,118
Stock issued for equity awards		722			7			209			—			—			216
Employee withholding taxes paid    related to net share settlement		(192	)		(2	)		(1,738	)		—			—			(1,740	)
Repurchases and cancellations of    common stock		(1,939	)		(19	)		(9,266	)		(10,915	)		—			(20,200	)
Balance at December 31, 2023		104,857		$	1,049		$	—		$	652,247		$	(111,956	)	$	541,340
Net earnings		—			—			—			29,244			—			29,244
Other comprehensive loss		—			—			—			—			(4,876	)		(4,876	)
Share-based compensation		—			—			3,964			—			—			3,964
Stock issued for equity awards		184			2			1,396			—			—			1,398
Employee withholding taxes paid    related to net share settlement		(1	)		(1	)		(19	)		—			—			(20	)
Repurchases and cancellations of    common stock		(1,526	)		(15	)		(5,341	)		(14,844	)		—			(20,200	)
Balance at March 31, 2024		103,514		$	1,035		$	—		$	666,647		$	(116,832	)	$	550,850

												Accumulated
							Additional					Other			Total
	Common Stock						Paid-in			Accumulated		Comprehensive			Stockholders’
	Shares			Amount			Capital			Earnings		Loss			Equity
Balance at September 30, 2022		106,970		$	1,070		$	4,241		$	440,172	$	(151,847	)	$	293,636
Net earnings		—			—			—			50,337		—			50,337
Other comprehensive income		—			—			—			—		25,234			25,234
Share-based compensation		—			—			5,135			—		—			5,135
Stock issued for equity awards		404			4			78			—		—			82
Employee withholding taxes paid    related to net share settlement		(90	)		(1	)		(1,125	)		—		—			(1,126	)
Balance at December 31, 2022		107,284		$	1,073		$	8,329		$	490,509	$	(126,613	)	$	373,298
Net earnings		—			—			—			40,861		—			40,861
Other comprehensive income		—			—			—			—		6,265			6,265
Share-based compensation		—			—			3,838			—		—			3,838
Stock issued for equity awards		266			3			1,638			—		—			1,641
Employee withholding taxes paid    related to net share settlement		(1	)		—			(15	)		—		—			(15	)
Balance at March 31, 2023		107,549		$	1,076		$	13,790		$	531,370	$	(120,348	)	$	425,888

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Six Months Ended March 31,
	2024			2023
Cash Flows from Operating Activities:
Net earnings	$	67,634		$	91,198
Adjustments to reconcile net earnings to net cash provided     by operating activities:
Depreciation and amortization		55,017			50,347
Share-based compensation expense		9,082			8,973
Amortization of deferred financing costs		1,272			1,311
Loss on early extinguishment of debt		2,037			601
Impairment of long-lived assets, including operating lease assets		—			1,765
Loss on disposal of equipment and other property		3			2
Deferred income taxes		171			862
Changes in (exclusive of effects of acquisitions):
Trade accounts receivable		(1,054	)		4,632
Accounts receivable, other		(10,141	)		(5,805	)
Inventory		(59,741	)		(68,355	)
Other current assets		(1,412	)		6,053
Other assets		(1,792	)		2,201
Operating leases, net		(2,072	)		(14,286	)
Accounts payable and accrued liabilities		32,314			108
Income taxes payable		(1,842	)		434
Other liabilities		(1,516	)		(393	)
Net cash provided by operating activities		87,960			79,648
Cash Flows from Investing Activities:
Payments for property and equipment, net of proceeds		(44,659	)		(42,181	)
Acquisitions, net of cash acquired		(218	)		—
Net cash used by investing activities		(44,877	)		(42,181	)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt		1,056,000			853,000
Repayments of long-term debt		(1,076,054	)		(898,093	)
Debt issuance costs		(8,332	)		(4,726	)
Proceeds from equity awards		1,614			1,723
Payments for common stock repurchased		(40,400	)		—
Employee withholding taxes paid related to net share settlement of equity awards		(1,760	)		(1,141	)
Net cash used by financing activities		(68,932	)		(49,237	)
Effect of foreign exchange rate changes on cash and cash equivalents		22			2,832
Net decrease in cash and cash equivalents		(25,827	)		(8,938	)
Cash and cash equivalents, beginning of period		123,001			70,558
Cash and cash equivalents, end of period	$	97,174		$	61,620
Supplemental Cash Flow Information:
Interest paid	$	48,253		$	35,191
Income taxes paid	$	32,007		$	32,077
Capital expenditures incurred but not paid	$	16,992		$	5,466

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

Sally Beauty Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of March 31, 2024, and September 30, 2023, our consolidated results of operations, consolidated comprehensive income and consolidated statements of stockholders’ equity for the three and six months ended March 31, 2024 and 2023, and consolidated cash flows for the six months ended March 31, 2024 and 2023.

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

2. Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to enhance segment disclosures for annual and interim consolidated financial statements, including significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”). For public companies, the amendments in the update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but do not expect the update to impact our consolidated results of operations or financial position.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but do not expect the update to impact our consolidated results of operations or financial position.

9

3. Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

	Six Months Ended March 31,
	2024			2023
Beginning Balance	$	14,038		$	13,460
Loyalty points and gift cards issued but not redeemed, net of estimated breakage		8,700			9,327
Revenue recognized from beginning liability		(9,997	)		(8,370	)
Ending Balance	$	12,741		$	14,417

See Note 11, Segment Reporting, for additional information regarding the disaggregation of our sales revenue.

4. Fair Value Measurements

We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date.

The three levels of that hierarchy are defined as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follow:

(in thousands)	Classification	Fair Value Hierarchy Level	March 31, 2024		September 30, 2023
Financial Assets:
Foreign exchange contracts
Non-designated cash flow hedges	Other current assets	Level 2	$	483	$	1,160
Interest rate swap	Other assets	Level 2		2,920		4,668
Total assets			$	3,403	$	5,828
.
Financial Liabilities:
Foreign exchange contracts
Designated cash flow hedges	Accrued liabilities	Level 2	$	1,301	$	—
Non-designated cash flow hedges	Accrued liabilities	Level 2		685		397
Total liabilities			$	1,986	$	397

The fair value of each asset and liability were measured using widely accepted valuation techniques, such as discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

10

Other fair value disclosures

The carrying amounts of cash equivalents, trade and other accounts receivable, and accounts payable and borrowing under our ABL facility approximate their respective fair values due to the short-term nature of these financial instruments. Carrying amounts and the related estimated fair value of our long-term debt, excluding finance lease obligations, debt issuance costs and original issue discounts, are as follows:

		March 31, 2024				September 30, 2023
(in thousands)	Fair Value Hierarchy Level	Carrying Value		Fair Value		Carrying Value		Fair Value
Long-term debt, excluding finance lease obligations
Senior notes	Level 1	$	600,000	$	593,250	$	679,961	$	662,962
Term loan B due 2030	Level 2		396,000		395,505		398,000		398,000
Total long-term debt		$	996,000	$	988,755	$	1,077,961	$	1,060,962

The fair values of our term loans were measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.

5. Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors (“Board”) approved a share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board approved a term extension of our share repurchase program to September 30, 2025. As of March 31, 2024, we had approximately $540.8 million of additional share repurchase authorizations remaining under our share repurchase program. For the three and six months ended March 31, 2024, we repurchased 1.5 million and 3.5 million shares of our common stock at a total cost of $20.0 million and $40.0 million, respectively, excluding the impact of excise taxes. For the three and six months ended March 31, 2023, we did not repurchase shares under our share repurchase program.

Accumulated Other Comprehensive Loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

	Foreign Currency Translation Adjustments			Interest Rate Swap			Foreign Exchange Contracts			Total
Balance at September 30, 2023	$	(124,846	)	$	3,716		$	(1,634	)	$	(122,764	)
Other comprehensive income (loss) before     reclassification, net of tax		7,449			152			(2,042	)		5,559
Reclassification to net earnings, net of tax		—			(1,656	)		2,029			373
Balance at March 31, 2024	$	(117,397	)	$	2,212		$	(1,647	)	$	(116,832	)

The tax impact for the changes in other comprehensive income (loss) and the reclassifications to net earnings was not material.

6. Weighted-Average Shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Weighted-average basic shares		104,276		107,453		105,117		107,294
Dilutive securities:
Stock option and stock award programs		2,804		2,253		2,764		2,205
Weighted-average diluted shares		107,080		109,706		107,881		109,499
Anti-dilutive options excluded from our computation of diluted shares		1,733		1,964		1,754		1,964

11

7. Goodwill and Intangible Assets

During the three months ended March 31, 2024, we completed our annual assessments for impairment of goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment requiring further quantitative testing. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and intangible assets.

At September 30, 2023, we determined that due to the recent decline in the Company's share price and market capitalization, among other factors, a quantitative assessment was required. Based on our September 30, 2023, quantitative assessment using a discounted cash flow, we estimated the fair value for our BSG reporting unit to be approximately 18% more than its carrying value. The critical assumptions used as part of our evaluation included a projected long-term revenue growth rate of 2.0% and a discount rate of 11.25%, based on a weighted-average cost of capital analysis (adjusted for company specific risk). Our September 30, 2023, quantitative assessment indicated that the fair value of our SBS segment was substantially higher than its carrying value. Goodwill allocated to our SBS and BSG reporting units, which are also defined as our SBS and BSG segment, was $84.9 million and $449.6 million, respectively, as of March 31, 2024.

	Three Months Ended March 31,				Six Months Ended March 31,
(in thousands)	2024		2023		2024		2023
Intangible assets amortization expense	$	791	$	866	$	1,651	$	1,875

For the six months ended March 31, 2024, changes in goodwill reflects the effects of foreign currency exchange rates of $1.8 million and adjustments of $0.4 million from the completion of our Goldwell of NY, Inc. acquisition fair value assessment. Additionally, the changes to other intangibles included effects of foreign currency exchange rates of $0.8 million.

8. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	March 31, 2024		September 30, 2023
Compensation and benefits	$	63,758	$	69,915
Deferred revenue		17,874		18,259
Rental obligations		10,677		11,266
Insurance reserves		6,931		6,656
Interest payable		4,758		13,447
Property and other taxes		1,379		2,617
Operating accruals and other		44,625		41,206
Total accrued liabilities	$	150,002	$	163,366

9. Short-term and Long-term Debt

At March 31, 2024, our ABL facility had $62.0 million in outstanding borrowings and $420.6 million available for borrowing, including the Canadian sub-facility, subject to borrowing base limitation, as reduced by outstanding letters of credit.

On February 12, 2024, we announced a registered public offering of 6.75% senior notes due 2032 (“2032 Senior Notes”). This offering was made pursuant to a shelf registration statement on Form S-3 filed with the SEC on May 10, 2021. On February 27, 2024, we closed on the 2032 Senior Notes and received $594.0 million in cash proceeds net of underwriter fees. The proceeds were used to repay the outstanding $680.0 million principal balance on the 5.625% Senior Notes due 2025 (the “2025 Senior Notes”). The 2032 Senior Notes were issued at par and bear interest at a fixed interest rate of 6.75%. Interest is paid semi-annually during our second and fourth fiscal quarters. The 2032 Senior Notes are guaranteed on a senior secured basis by the guarantors who have guaranteed obligations under our senior secured credit facilities and our existing notes. In connection with the issuance, we incurred approximately $8.8 million in debt issuance costs that is being amortized using the effective interest rate method through the life of the notes.

Additionally on February 12, 2024, we issued a notice to redeem the entire $680.0 million aggregate outstanding principal amount of the 2025 Senior Notes that remained outstanding on March 13, 2024, at a redemption price equal to 100.00% of the principal amount of the 2025 Senior Notes, plus accrued and unpaid interest to, but not including, the redemption date. On March 13, 2024, we redeemed the 2025 Senior Notes with the proceeds of our newly-issued 2032 Senior Notes, cash on hand prior to the new 2032 Senior Notes, and ABL borrowings. In connection with this redemption, we recognized a $2.0 million loss on the extinguishment of debt within interest expense related to unamortized debt issuance costs.

12

10. Derivative Instruments and Hedging Activities

During the six months ended March 31, 2024, we did not purchase or hold any derivative instruments for trading or speculative purposes. See Note 4, Fair Value Measurements, for the classification and fair value of our derivative instruments.

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At March 31, 2024, we held forwards, which expire ratably through September 30, 2024, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
Mexican Peso	$	11,490
Euro		5,597
Canadian Dollar		5,505
Total	$	22,592

Quarterly, the changes in fair value related to these foreign currency forwards are recorded into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold, based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended March 31, 2024 and 2023, we recognized a loss of $0.6 million and a loss of $0.2 million, respectively. For the six months ended March 31, 2024 and 2023, we recognized a loss of $2.0 million and a gain of $0.1 million, respectively. Based on March 31, 2024, valuations and exchange rates, we expect to reclassify losses of approximately $1.8 million out of AOCL and into cost of goods sold over the next 12 months.

Interest Rate Swap

In April 2023, we entered into a three-year interest rate swap with an initial notional amount of $200 million (the “interest rate swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The interest rate swap involves fixed monthly payments at the contract rate of 3.705%, and in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The interest rate swap will mature in April 2026 and is designated as a cash flow hedge. Changes in the fair value of the interest rate swap are recorded quarterly, net of income tax, and included in AOCL.

For the three and six months ended March 31, 2024, we recognized income of $0.8 million and $1.7 million, respectively, into interest expense on our condensed consolidated statements of earnings related to the interest rate swap. At March 31, 2024, we expect to reclassify gains of approximately $2.4 million out of AOCL and into interest expense over the next 12 months.

Interest Rate Caps

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our prior term loan due 2024. The interest rate caps were comprised of individual caplets and were designated as cash flow hedges. Accordingly, the changes in fair value of the interest rate caps were recorded quarterly, net of income tax, and included in AOCL. During fiscal year 2023, we early settled both interest rate caps due to the forecasted transactions being hedged no longer occurring as a result of the repayment of our prior term loan. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended March 31, 2023. For the six months ended March 31, 2023, we recognized income of $2.8 million into interest expense on our condensed consolidated statements of earnings related to the caps.

Non-Designated Derivative Instruments

We also use foreign exchange contracts to mitigate our exposure to exchange rate changes in connection with certain intercompany balances not permanently invested. At March 31, 2024, we held forwards, which settle on various dates in the first month of the next two fiscal quarters, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
British Pound	$	44,761
Mexican Peso		22,547
Euro		20,928
Canadian Dollar		17,009
Total	$	105,245

We record changes in fair value and realized gains or losses related to these foreign currency forwards into selling, general and administrative expenses. For the three months ended March 31, 2024 and 2023, the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $0.3 million and losses of $1.5 million, respectively. For the six months

13

ended March 31, 2024 and 2023, the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $1.6 million and losses of $1.1 million, respectively.

11. Segment Reporting

Segment data for the three and six months ended March 31, 2024 and 2023, is as follows (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024			2023
Net sales:
Sally Beauty Supply ("SBS")	$	513,241	$	530,246	$	1,036,479		$	1,079,718
Beauty Systems Group ("BSG")		395,120		388,466		803,184			796,049
Total	$	908,361	$	918,712	$	1,839,663		$	1,875,767
Earnings before provision for income taxes:
Segment operating earnings:
SBS	$	76,820	$	92,134	$	154,449		$	191,308
BSG		43,015		37,260		87,642			86,907
Segment operating earnings		119,835		129,394		242,091			278,215
Unallocated expenses		60,198		50,712		113,416			102,539
Restructuring		63		7,274		(22	)		17,680
Consolidated operating earnings		59,574		71,408		128,697			157,996
Interest expense		20,523		16,685		37,837			34,608
Earnings before provision for income taxes	$	39,051	$	54,723	$	90,860		$	123,388

Sales between segments, which are eliminated in consolidation, were not material during the three and six months ended March 31, 2024 and 2023.

14

Disaggregation of net sales by segment

Periodically, we make minor adjustments to our product hierarchy, that impacts the roll-up of our merchandise categories. As a result, certain prior year amounts have been reclassified to conform to current year presentation. The following tables disaggregate our segment revenues by merchandise category.

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Hair color		39.6	%		39.8	%		39.2	%		39.2	%
Hair care		25.2	%		24.3	%		24.6	%		23.9	%
Styling tools and supplies		17.0	%		17.9	%		17.6	%		18.7	%
Nail		9.9	%		10.0	%		10.0	%		10.2	%
Skin and cosmetics		7.9	%		7.5	%		8.0	%		7.4	%
Other beauty items		0.4	%		0.5	%		0.6	%		0.6	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Hair care		41.8	%		42.0	%		42.4	%		42.8	%
Hair color		41.5	%		40.6	%		40.4	%		39.4	%
Styling tools and supplies		10.6	%		10.8	%		10.7	%		10.8	%
Skin and cosmetics		3.5	%		3.7	%		3.9	%		4.1	%
Nail		2.3	%		2.7	%		2.4	%		2.7	%
Other beauty items		0.3	%		0.2	%		0.2	%		0.2	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

The following tables disaggregate our segment revenue by sales channels:

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Company-operated stores		93.4	%		93.6	%		93.3	%		93.6	%
E-commerce		6.6	%		6.4	%		6.7	%		6.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Company-operated stores		67.8	%		67.5	%		68.2	%		66.9	%
E-commerce		14.1	%		13.7	%		13.9	%		13.7	%
Distributor sales consultants		10.5	%		11.4	%		10.6	%		12.0	%
Franchise stores		7.6	%		7.4	%		7.3	%		7.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

15

12. Restructuring

Restructuring expenses, included in Cost of Goods Sold (“COGS”) and Restructuring for the three and six months ended March 31, 2024 and 2023, are as follows (in thousands):

	Three Months Ended March 31,					Six Months Ended March 31,
	2024		2023			2024			2023
Included in COGS (a)
Distribution Center Consolidation and Store Optimization Plan	$	—	$	(2,362	)	$	—		$	(5,042	)
Included in Restructuring (b)
Distribution Center Consolidation and Store Optimization Plan	$	63	$	7,274		$	(22	)	$	17,680

(a)Amounts included in COGS relate to adjustments to our expected obsolescence reserve related to the Plan (as defined below).

(b)For the three and six months ended March 31, 2023, restructuring consisted of closing costs related to lease terminations and employee termination benefits. The six months ended March 31, 2023, also includes $2.1 million in impairment charges.

Distribution Center Consolidation and Store Optimization Plan

In the fourth quarter of fiscal year 2022, our Board approved the Distribution Center Consolidation and Store Optimization Plan (“the Plan”) authorizing the closure of 330 SBS stores and 35 BSG stores, and the closure of two BSG distribution centers in Clackamas, Oregon and Pottsville, Pennsylvania. Stores identified for early closure were part of a strategic evaluation which included a market analysis of certain locations where we believed we would be able to recapture demand and improve profitability.

The Plan has been substantially completed, as the remaining two BSG stores were closed earlier this fiscal year. However, we may still incur future immaterial charges related to store closures such as exit costs, lease negotiation penalties and adjustments to estimates. As of March 31, 2024, there were no material outstanding liabilities for exit costs or involuntary employee termination benefits.

16

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, including the Risk Factors sections therein, and information contained elsewhere in this Quarterly Report, including the condensed consolidated interim financial statements and notes to those financial statements.

Financial Summary for the Three Months Ended March 31, 2024

•Consolidated net sales for the three months ended March 31, 2024, decreased $10.4 million, or 1.1%, to $908.4 million, compared to the three months ended March 31, 2023. Consolidated net sales included a net favorable impact from changes in foreign currency exchange rates of $4.6 million;

•Consolidated comparable sales decreased 1.5% for the three months ended March 31, 2024;

•Consolidated gross profit for the three months ended March 31, 2024, decreased $5.3 million, or 1.1%, to $463.1 million, compared to the three months ended March 31, 2023. Consolidated gross margin remained unchanged at 51.0% for the three months ended March 31, 2024, compared to the three months ended March 31, 2023;

•Consolidated operating earnings for the three months ended March 31, 2024, decreased $11.8 million, or 16.6%, to $59.6 million, compared to the three months ended March 31, 2023. Operating margin decreased 120 bps to 6.6% for the three months ended March 31, 2024, compared to the three months ended March 31, 2023;

•For the three months ended March 31, 2024, our consolidated net earnings decreased $11.6 million, or 28.4%, to $29.2 million, compared to the three months ended March 31, 2023;

•For the three months ended March 31, 2024, our diluted earnings per share was $0.27 compared to $0.37 for the three months ended March 31, 2023;

•Cash provided by operations was $36.9 million for the three months ended March 31, 2024, compared to $24.7 million for the three months ended March 31, 2023; and

•During the quarter, we issued $600.0 million in 2032 Senior Notes and used the proceeds, along with ABL borrowings and cash, to repay in full our $680.0 million in 2025 Senior Notes.

Comparable Sales

We believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. Our comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and from e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquired stores are excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.

17

Overview

Key Operating Metrics

The following table sets forth, for the periods indicated, information concerning key measures we rely on to evaluate our operating performance (dollars in thousands):

	Three Months Ended March 31,												Six Months Ended March 31,
	2024			2023			Increase (Decrease)						2024			2023			Increase (Decrease)
Net sales:
SBS	$	513,241		$	530,246		$	(17,005	)		(3.2	)%	$	1,036,479		$	1,079,718		$	(43,239	)		(4.0	)%
BSG		395,120			388,466			6,654			1.7	%		803,184			796,049			7,135			0.9	%
Consolidated	$	908,361		$	918,712		$	(10,351	)		(1.1	)%	$	1,839,663		$	1,875,767		$	(36,104	)		(1.9	)%
Gross profit:
SBS	$	307,578		$	317,117		$	(9,539	)		(3.0	)%	$	614,138		$	640,592		$	(26,454	)		(4.1	)%
BSG		155,494			151,222			4,272			2.8	%		316,110			316,321			(211	)		(0.1	)%
Consolidated	$	463,072		$	468,339		$	(5,267	)		(1.1	)%	$	930,248		$	956,913		$	(26,665	)		(2.8	)%
Segment gross margin:
SBS		59.9	%		59.8	%	10			bps				59.3	%		59.3	%	—			bps
BSG		39.4	%		38.9	%	50			bps				39.4	%		39.7	%	(30)			bps
Consolidated		51.0	%		51.0	%	—			bps				50.6	%		51.0	%	(40)			bps
Net earnings:
Segment operating earnings:
SBS	$	76,820		$	92,134		$	(15,314	)		(16.6	)%	$	154,449		$	191,308		$	(36,859	)		(19.3	)%
BSG		43,015			37,260			5,755			15.4	%		87,642			86,907			735			0.8	%
Segment operating earnings		119,835			129,394			(9,559	)		(7.4	)%		242,091			278,215			(36,124	)		(13.0	)%
Unallocated expenses and restructuring(a)		60,261			57,986			2,275			3.9	%		113,394			120,219			(6,825	)		(5.7	)%
Consolidated operating earnings		59,574			71,408			(11,834	)		(16.6	)%		128,697			157,996			(29,299	)		(18.5	)%
Interest expense		20,523			16,685			3,838			23.0	%		37,837			34,608			3,229			9.3	%
Earnings before provision for income taxes		39,051			54,723			(15,672	)		(28.6	)%		90,860			123,388			(32,528	)		(26.4	)%
Provision for income taxes		9,807			13,862			(4,055	)		(29.3	)%		23,226			32,190			(8,964	)		(27.8	)%
Net earnings	$	29,244		$	40,861		$	(11,617	)		(28.4	)%	$	67,634		$	91,198		$	(23,564	)		(25.8	)%
	.
Comparable sales growth (decline):
SBS		(4.0	)%		9.1	%	(1,310)			bps				(3.0	)%		5.9	%	(890)			bps
BSG		2.0	%		1.3	%	70			bps				1.3	%		(0.2	)%	150			bps
Consolidated		(1.5	)%		5.7	%	(720)			bps				(1.1	)%		3.3	%	(440)			bps
Number of stores at end-of-period (including franchises):
SBS		3,134			3,143			(9	)		(0.3	)%
BSG		1,334			1,341			(7	)		(0.5	)%
Consolidated		4,468			4,484			(16	)		(0.4	)%

(a)Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. Additionally, unallocated expenses include costs associated with our Fuel for Growth initiative.

18

Results of Operations

The Three Months Ended March 31, 2024, compared to the Three Months Ended March 31, 2023

Net Sales

SBS. The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales	$	(21,210	)
Sales outside comparable sales (a)		(341	)
Foreign currency exchange		4,546
Total	$	(17,005	)

(a)Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months.

SBS's net sales decrease was primarily driven by a decline in comparable sales, partially offset by favorable impacts from foreign currency exchange rates. SBS’s decline in comparable sales was driven by a result of fewer transactions.

BSG. The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales	$	7,624
Sales outside comparable sales (a)		(1,067	)
Foreign currency exchange		97
Total	$	6,654

(a)Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months and sales from acquired stores.

BSG's net sales increase was primarily driven by an increase in comparable sales, reflecting expanded distribution, new brand innovation and improving salon demand trends.

Gross Profit

SBS. SBS’s gross profit decreased for the three months ended March 31, 2024, as a result of a decrease in net sales, partially offset by a higher gross margin on units sold. SBS’s gross margin improvement was driven primarily by lower distribution and freight costs from supply chain efficiencies, partially offset by the impact of favorable adjustments to our expected obsolescence reserve related to the Plan in the prior year.

BSG. BSG’s gross profit increased for the three months ended March 31, 2024, as a result of an increase in net sales and a higher gross margin on units sold. BSG’s gross margin improvement was driven by lower distribution and freight costs from supply chain efficiencies, partially offset by lower product margins primarily from higher take rate on promotions and brand mix.

Selling, General and Administrative Expenses

SBS. SBS’s selling, general and administrative expenses increased $5.8 million, or 2.6%, for the three months ended March 31, 2024, and included an unfavorable impact from foreign exchange rates of $1.8 million. As a percentage of SBS net sales, selling, general and administrative expense for the three months ended March 31, 2024, was 45.0% compared to 42.4% for the three months ended March 31, 2023. The increase as a percentage of sales was primarily due to higher labor and rent costs.

BSG. BSG’s selling, general and administrative expenses decreased $1.5 million, or 1.3%, for the three months ended March 31, 2024. As a percentage of BSG net sales, selling, general and administrative expense for the three months ended March 31, 2024, was 28.5% compared to 29.3% for the three months ended March 31, 2023. The decrease as a percentage of sales was primarily due to lower delivery expense.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $9.5 million, or 18.7%, for the three months ended March 31, 2024, primarily due to expenses in connection with our Fuel for Growth initiative in the current year and higher health insurance costs, partially offset by lower accrued bonus expense.

Restructuring

The decrease in restructuring was primarily due to the lapping of expenses incurred in connection with our Distribution Center Consolidation and Store Optimization Plan in the prior year for $7.3 million. See Note 12, Restructuring, in Item 1 of this quarterly report for more information on the Plan.

19

Interest Expense

The increase in interest expense is primarily due to higher interest rates on our variable rate debt and an increase in our losses on debt extinguishment, partially offset by lower average outstanding borrowings on our ABL facility during the current quarter. See Note 9, Short-term and Long-term Debt, and Note 10, Derivative Instruments and Hedging Activities, in Item 1 of this quarterly report for more information on our debt and interest rate swap that has helped mitigate some of the additional interest costs resulting from higher interest rates.

The Six Months Ended March 31, 2024, compared to the Six Months Ended March 31, 2023

Net Sales

SBS. The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales	$	(31,089	)
Sales outside comparable sales (a)		(25,442	)
Foreign currency exchange		13,292
Total	$	(43,239	)

(a)Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months.

SBS's net sales decrease was primarily driven by the impact of lower comparable sales and store closures primarily in connection with the Plan in an amount of approximately $23.6 million, partially offset by a significant portion of these sales being recaptured in other locations included within comparable sales and a favorable impact from foreign currency exchange rates. SBS’s comparable sales decline was a result of fewer transactions, partially offset by growth in our average unit retail, driven by inflationary impacts and pricing leverage.

BSG. The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales	$	10,497
Sales outside comparable sales (a)		(3,362	)
Foreign currency exchange		—
Total	$	7,135

(a)Includes closed stores, including stores closed under the Plan, net of stores opened for less than 14 months and sales from acquired stores.

BSG's net sales increase was primarily driven by an increase in comparable sales, reflecting expanded distribution, new brand innovation and improving salon demand trends, partially offset by the impact of store closures.

Gross Profit

SBS. SBS’s gross profit decreased for the six months ended March 31, 2024, as a result of a decrease in net sales. SBS’s gross margin was flat due to lower distribution and freight costs from supply chain efficiencies, offset by the impact of favorable adjustments to our expected obsolescence reserve related to the Plan in the prior year.

BSG. BSG’s gross profit was flat for the six months ended March 31, 2024, as a result of a lower gross margin on units sold, offset by an increase in net sales. BSG’s gross margin decline was driven by unfavorable fixed cost absorption, shrink expense, and adjustments to our expected obsolescence reserve related to the Plan in the prior year, partially offset by lower distribution and freight costs from supply chain efficiencies and higher product margins primarily from higher take rate on promotions and brand mix.

Selling, General and Administrative Expenses

SBS. SBS’s selling, general and administrative expenses increased $10.4 million, or 2.3%, for the six months ended March 31, 2024, and included an unfavorable impact from foreign exchange rates of $5.1 million and cost savings from store closures in connection with the Plan. As a percentage of SBS net sales, selling, general and administrative expense for the six months ended March 31, 2024, was 44.4% compared to 41.6% for the six months ended March 31, 2023. The increase as a percentage of sales was due to higher labor costs, rent costs, and advertising expenses.

BSG. BSG’s selling, general and administrative expenses decreased $0.9 million, or 0.4%, for the six months ended March 31, 2024. As a percentage of BSG net sales, selling, general and administrative expense for the six months ended March 31, 2024, was 28.4% compared to 28.8% for the six months ended March 31, 2023. The decrease as a percentage of sales was driven primarily by lower delivery expense.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $10.9 million, or 10.6%, for the six months ended March 31, 2024, primarily due to expenses in connection with our Fuel for Growth initiative in the current year, partially offset by lower accrued bonus expense.

20

Restructuring

The decrease in restructuring was primarily due to the lapping of expenses incurred in connection with our Distribution Center Consolidation and Store Optimization Plan in the prior year for $17.7 million. See Note 12, Restructuring, in Item 1 of this quarterly report for more information on the Plan.

Interest Expense

The increase in interest expense is primarily due to higher interest rates on our variable rate debt and an increase in our losses on debt extinguishment, partially offset by lower average outstanding borrowings on our ABL facility during the current year. See Note 9, Short-term and Long-term Debt, and Note 10, Derivative Instruments and Hedging Activities, in Item 1 of this quarterly report for more information on our debt and interest rate swap that has helped mitigate some of the additional interest costs resulting from higher interest rates.

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are cash from operations, cash and cash equivalents and borrowings under our ABL facility. A substantial portion of our liquidity needs arise from funding the costs of our operations, working capital, capital expenditures, debt interest and principal payments. Additionally, under our share repurchase program (see below for more details) we will from time-to-time repurchase shares of our common stock on the open market to return value to our shareholders. At March 31, 2024, we had $517.8 million in our liquidity pool, which includes $420.6 million available for borrowing under our ABL facility and cash and cash equivalents of $97.2 million.

Our working capital (current assets less current liabilities) decreased $12.1 million, to $636.6 million at March 31, 2024, compared to $648.7 million at September 30, 2023. The decrease was primarily driven by the impacts of our debt activity during the quarter, resulting in higher borrowings under our ABL facility and a decrease in cash and cash equivalents, and due to the timing of AP payments. These impacts were partially offset by an increase in inventory, as a result of expanded distribution rights in BSG, vendor price increases, the impact of foreign exchange rates of $4.7 million, and by fewer accrued liabilities, driven by the timing of interest and payroll payments.

We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.

Cash Flows

	Six Months Ended March 31,
(in thousands)	2024			2023
Net cash provided by operating activities	$	87,960		$	79,648
Net cash used by investing activities		(44,877	)		(42,181	)
Net cash used by financing activities		(68,932	)		(49,237	)

Net Cash Provided by Operating Activities

The increase in cash provided by operating activities was driven by the timing of account payables payments and inventory purchases and lease contract termination and severance payments in connection with the Plan in the prior year, partially offset by the timing of cash receipts from customers.

Net Cash Used by Investing Activities

The increase in cash used by investing activities was driven by higher capital expenditures related to store improvements.

Net Cash Used by Financing Activities

The increase in cash used by financing activities was primarily due to shares repurchased in the current year under our share repurchases program, partially offset by fewer reductions in our debt outstanding in the current year compared to the prior year.

Debt and Guarantor Financial Information

During the three months ending March 31, 2024, we issued $600.0 million in 2032 Senior Notes and used the proceeds, together with cash on hand and borrowings under our ABL facility, to repay in full our 2025 Senior Notes. See Note 9, Short-term and Long-term Debt, in Item 1 of this quarterly report for more information on the issuance and repayment of debt.

21

At March 31, 2024, we had $1.1 billion in outstanding debt principal, excluding finance lease obligations, unamortized debt issuance costs and debt discounts, in the aggregate, of $13.7 million. Our debt consists of $600.0 million in 2032 Senior Notes outstanding, $396.0 million remaining on our term loan and $62.0 million in outstanding borrowings under our ABL facility.

We utilize our ABL facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL facility are generally paid down with cash provided by our operating activities. During the six months ended March 31, 2024, the weighted average interest rate on our borrowings under the ABL facility was 7.73%.

We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

Guarantor Financial Information

Our 2032 Senior Notes were issued by our wholly-owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly-owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities has been eliminated.

The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of March 31, 2024, and September 30, 2023:

(in thousands)	March 31, 2024		September 30, 2023
Cash and cash equivalents	$	32,784	$	66,148
Inventory	$	787,351	$	735,853
Intercompany receivable	$	—	$	1,658
Current assets	$	915,327	$	890,462
Total assets	$	2,073,759	$	2,076,413
Current liabilities	$	524,496	$	468,202
Intercompany payable	$	2,611	$	—
Total liabilities	$	1,984,754	$	2,011,075

The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for six months ended March 31, 2024 (in thousands):

Net sales	$	1,479,062
Gross profit	$	757,827
Earnings before provision for income taxes	$	72,048
Net Earnings	$	54,377

Share Repurchase Programs

Under our current share repurchase program, we may from time-to-time repurchase our common stock on the open market. During the three and six months ended March 31, 2024, we repurchased 1.5 million and 3.5 million shares of our common stock for $20.0 million and $40.0 million, respectively, under our share repurchase program, excluding the impact of excise taxes. During the three and six months ended March 31, 2023, no shares were repurchased in connection with our share repurchase program. See Note 5, Stockholders’ Equity, for more information about our share repurchase program.

Contractual Obligations

Other than our debt, as discussed above, there have been no material changes outside the ordinary course of our business to our contractual obligations since September 30, 2023.

Off-Balance Sheet Financing Arrangements

At March 31, 2024, and September 30, 2023, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates or assumptions since September 30, 2023.

22

Recent Accounting Pronouncements

See Note 2 of the Notes to Condensed Consolidated Financial Statements in Item 1 – “Financial Statements” in Part I – Financial Information.

23

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from September 30, 2023. See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Item 4. Controls and Procedures

Controls Evaluation and Related CEO and CFO Certifications. Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2024. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Limitations on the Effectiveness of Controls. We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

Scope of the Controls Evaluation. The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

Conclusions regarding Disclosure Controls. Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of March 31, 2024, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting. During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

24

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

Information regarding shares of common stock we repurchased during the second quarter of fiscal year 2024, excluding the impact of excise taxes, is as follows:

Fiscal Period	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)(2)		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
Jan 1 -Jan 31, 2024		—	$	—		—	$	560,792,432
Feb 1 - Feb 29, 2024		1,209,241		13.22		1,209,241		544,801,708
Mar 1 - Mar 31, 2024		317,227		12.64		317,227		540,792,435
Total this quarter		1,526,468	$	13.10		1,526,468	$	540,792,435

(1)The table above does not include 1,378 shares of the Company’s common stock surrendered by grantees during the quarter to satisfy tax withholding obligations due upon the vesting of equity-based awards under the Company’s share-based compensation plans.

(2)In July 2021, we announced that our Board of Directors had approved a term extension to our share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock over an approximate four-year period expiring on September 30, 2025.

Item 5. Other Information

During the quarter ended March 31, 2024, no director or officer of the Company adopted, modified, or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408(a) of Regulation S-K.

25

Item 6. Exhibits

Exhibit No.	Description
3.1	Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014
3.2	Amended and Restated Bylaws of Sally Beauty Holdings, Inc., dated April 26, 2017, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 28, 2017
4.1	Fifth Supplemental Indenture, dated as of February 27, 2024, by and among Sally Holdings LLC, Sally Capital Inc., the guarantors listed therein and Computershare Trust Company, N.A, which is incorporated herein by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on February 27, 2024
22	List of Subsidiary Guarantors*
31.1	Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis*
31.2	Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier*
32.1	Section 1350 Certification of Denise Paulonis*
32.2	Section 1350 Certification of Marlo M. Cormier*
101	The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.
104	The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, formatted in iXBRL (contained in Exhibit 101).

* Included herewith

26

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SALLY BEAUTY HOLDINGS, INC.
		(Registrant)
Date: May 9, 2024
	By:	/s/ Marlo M. Cormier
		Marlo M. Cormier
		Senior Vice President, Chief Financial Officer
		For the Registrant and as its Principal Financial Officer

27

EX-22

Exhibit 22

LIST OF SUBSIDIARY GUARANTORS

As of March 31, 2024, each of the following subsidiaries of Sally Beauty Holdings, Inc. is a guarantor of our unsecured 6.75% Senior Notes due 2032. The guarantees are joint and several, and full and unconditional. Sally Beauty Holdings, Inc. owns, directly or indirectly, 100% of each guarantor subsidiary.

Exact Name of Registrant as Specified in Its Charter	State of Incorporation or Organization
Arcadia Beauty Labs LLC	Delaware
Arcadia Beauty Labs II LLC	Delaware
Armstrong McCall Holdings, Inc.	Texas
Armstrong McCall Holdings, L.L.C.	Delaware
Armstrong McCall, L.P.	Texas
Armstrong McCall Management, L.C.	Texas
Beauty Holding LLC	Delaware
Beauty Systems Group LLC	Virginia
Diorama Services Company, LLC	Delaware
Innovations-Successful Salon Services	California
Loxa Beauty LLC	Indiana
Neka Salon Supply, Inc.	New Hampshire
Procare Laboratories, Inc.	Delaware
Sally Beauty Holdings, Inc.	Delaware
Sally Beauty International Finance LLC	Delaware
Sally Beauty Military Supply LLC	Delaware
Sally Beauty Supply LLC	Virginia
Sally Investment Holdings LLC	Delaware
Salon Success International, LLC	Florida

EX-31.1

Exhibit 31.1

CERTIFICATION
PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Denise Paulonis, certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 of Sally Beauty Holdings, Inc.;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024
	By:	/s/ Denise Paulonis
		Denise Paulonis
		Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION
PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Marlo M. Cormier, certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 of Sally Beauty Holdings, Inc.;

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024
	By:	/s/ Marlo M. Cormier
		Marlo M. Cormier
		Senior Vice President, Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sally Beauty Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Denise Paulonis, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	By:	/s/ Denise Paulonis
		Denise Paulonis
		Chief Executive Officer
Date: May 9, 2024

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sally Beauty Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marlo M. Cormier, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	By:	/s/ Marlo M. Cormier
		Marlo M. Cormier
		Senior Vice President, Chief Financial Officer
Date: May 9, 2024

XML

Document and Entity Information - shares	6 Months Ended
	Mar. 31, 2024	May 03, 2024
Cover [Abstract]
Entity Registrant Name	SALLY BEAUTY HOLDINGS, INC.
Entity Central Index Key	0001368458
Document Type	10-Q
Document Period End Date	Mar. 31, 2024
Trading Symbol	SBH
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	1-33145
Entity Tax Identification Number	36-2257936
Entity Address, Address Line One	3001 Colorado Boulevard
Entity Address, City or Town	Denton
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	76210
City Area Code	940
Local Phone Number	898-7500
Security Exchange Name	NYSE
Title of 12(b) Security	Common Stock, $0.01 par value
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding		103,514,140
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 97,174	$ 123,001
Trade accounts receivable, net	34,693	33,421
Accounts receivable, other	52,868	42,454
Inventory	1,039,752	975,218
Other current assets	55,836	53,903
Total current assets	1,280,323	1,227,997
Property and equipment, net of accumulated depreciation of $833,581 at March 31, 2024, and $780,212 at September 30, 2023	273,175	297,779
Operating lease assets	562,770	570,657
Goodwill	534,494	533,081
Intangible assets, excluding goodwill, net of accumulated amortization of $31,821 at March 31, 2024, and $30,587 at September 30, 2023	54,088	55,171
Other assets	41,692	40,565
Total assets	2,746,542	2,725,250
Current liabilities:
Current maturities of long-term debt	66,164	4,173
Accounts payable	289,606	258,884
Accrued liabilities	150,002	163,366
Current operating lease liabilities	137,631	150,479
Income taxes payable	366	2,355
Total current liabilities	643,769	579,257
Long-term debt	978,360	1,065,811
Long-term operating lease liabilities	458,030	455,071
Other liabilities	21,626	23,139
Deferred income tax liabilities, net	93,907	93,224
Total liabilities	2,195,692	2,216,502
Stockholders’ equity:
Common stock, $0.01 par value. Authorized 500,000 shares; 103,514 and 106,266 shares issued and shares outstanding at March 31, 2024, and September 30, 2023, respectively	1,035	1,063
Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued
Additional paid-in capital		5,677
Accumulated earnings	666,647	624,772
Accumulated other comprehensive loss, net of tax	(116,832)	(122,764)
Total stockholders’ equity	550,850	508,748
Total liabilities and stockholders’ equity	$ 2,746,542	$ 2,725,250

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Property and equipment, accumulated depreciation (in dollars)	$ 833,581	$ 780,212
Intangible assets, excluding goodwill, accumulated amortization (in dollars)	$ 31,821	$ 30,587
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, Authorized shares	500,000,000	500,000,000
Common stock, shares issued	103,514,000	106,266,000
Common stock, shares outstanding	103,514,000	106,266,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, Authorized shares	50,000,000	50,000,000
Preferred stock, shares issued	0	0

XML

Condensed Consolidated Statements of Earnings - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 908,361	$ 918,712	$ 1,839,663	$ 1,875,767
Cost of goods sold	445,289	450,373	909,415	918,854
Gross profit	463,072	468,339	930,248	956,913
Selling, general and administrative expenses	403,435	389,657	801,573	781,237
Restructuring	63	7,274	(22)	17,680
Operating earnings	59,574	71,408	128,697	157,996
Interest expense	20,523	16,685	37,837	34,608
Earnings before provision for income taxes	39,051	54,723	90,860	123,388
Provision for income taxes	9,807	13,862	23,226	32,190
Net earnings	$ 29,244	$ 40,861	$ 67,634	$ 91,198
Earnings per share:
Basic	$ 0.28	$ 0.38	$ 0.64	$ 0.85
Diluted	$ 0.27	$ 0.37	$ 0.63	$ 0.83
Weighted-average shares:
Basic	104,276	107,453	105,117	107,294
Diluted	107,080	109,706	107,881	109,499

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ 29,244	$ 40,861	$ 67,634	$ 91,198
Other comprehensive income (loss):
Foreign currency translation adjustments	(6,928)	9,445	7,449	35,386
Interest rate swap, net of tax	1,584		(1,504)
Interest rate caps, net of tax		(2,163)		(1,960)
Foreign exchange contracts, net of tax	468	(1,017)	(13)	(1,927)
Other comprehensive income (loss), net of tax	(4,876)	6,265	5,932	31,499
Total comprehensive income	$ 24,368	$ 47,126	$ 73,566	$ 122,697

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Loss
Balance at Sep. 30, 2022	$ 293,636	$ 1,070	$ 4,241	$ 440,172	$ (151,847)
Balance (in shares) at Sep. 30, 2022		106,970
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	50,337			50,337
Other comprehensive income (loss)	25,234				25,234
Share-based compensation	5,135		5,135
Stock issued for equity awards	82	$ 4	78
Stock issued for equity awards (in shares)		404
Employee withholding taxes paid related to net share settlement	(1,126)	$ (1)	(1,125)
Employee withholding taxes paid related to net share settlement (in shares)		(90)
Balance at Dec. 31, 2022	373,298	$ 1,073	8,329	490,509	(126,613)
Balance (in shares) at Dec. 31, 2022		107,284
Balance at Sep. 30, 2022	293,636	$ 1,070	4,241	440,172	(151,847)
Balance (in shares) at Sep. 30, 2022		106,970
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	91,198
Other comprehensive income (loss)	31,499
Balance at Mar. 31, 2023	425,888	$ 1,076	13,790	531,370	(120,348)
Balance (in shares) at Mar. 31, 2023		107,549
Balance at Dec. 31, 2022	373,298	$ 1,073	8,329	490,509	(126,613)
Balance (in shares) at Dec. 31, 2022		107,284
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	40,861			40,861
Other comprehensive income (loss)	6,265				6,265
Share-based compensation	3,838		3,838
Stock issued for equity awards	1,641	$ 3	1,638
Stock issued for equity awards (in shares)		266
Employee withholding taxes paid related to net share settlement	(15)		(15)
Employee withholding taxes paid related to net share settlement (in shares)		(1)
Balance at Mar. 31, 2023	425,888	$ 1,076	13,790	531,370	(120,348)
Balance (in shares) at Mar. 31, 2023		107,549
Balance at Sep. 30, 2023	$ 508,748	$ 1,063	5,677	624,772	(122,764)
Balance (in shares) at Sep. 30, 2023	106,266	106,266
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	$ 38,390			38,390
Other comprehensive income (loss)	10,808				10,808
Share-based compensation	5,118		5,118
Stock issued for equity awards	216	$ 7	209
Stock issued for equity awards (in shares)		722
Employee withholding taxes paid related to net share settlement	(1,740)	$ (2)	(1,738)
Employee withholding taxes paid related to net share settlement (in shares)		(192)
Repurchases and cancellations of common stock	(20,200)	$ (19)	(9,266)	(10,915)
Repurchases and cancellations of common stock (in shares)		(1,939)
Balance at Dec. 31, 2023	541,340	$ 1,049		652,247	(111,956)
Balance (in shares) at Dec. 31, 2023		104,857
Balance at Sep. 30, 2023	$ 508,748	$ 1,063	5,677	624,772	(122,764)
Balance (in shares) at Sep. 30, 2023	106,266	106,266
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	$ 67,634
Other comprehensive income (loss)	5,932
Balance at Mar. 31, 2024	$ 550,850	$ 1,035		666,647	(116,832)
Balance (in shares) at Mar. 31, 2024	103,514	103,514
Balance at Dec. 31, 2023	$ 541,340	$ 1,049		652,247	(111,956)
Balance (in shares) at Dec. 31, 2023		104,857
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	29,244			29,244
Other comprehensive income (loss)	(4,876)				(4,876)
Share-based compensation	3,964		3,964
Stock issued for equity awards	1,398	$ 2	1,396
Stock issued for equity awards (in shares)		184
Employee withholding taxes paid related to net share settlement	(20)	$ (1)	(19)
Employee withholding taxes paid related to net share settlement (in shares)		(1)
Repurchases and cancellations of common stock	(20,200)	$ (15)	$ (5,341)	(14,844)
Repurchases and cancellations of common stock (in shares)		(1,526)
Balance at Mar. 31, 2024	$ 550,850	$ 1,035		$ 666,647	$ (116,832)
Balance (in shares) at Mar. 31, 2024	103,514	103,514

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net Income (Loss)	$ 67,634	$ 91,198
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	55,017	50,347
Share-based compensation expense	9,082	8,973
Amortization of deferred financing costs	1,272	1,311
Loss on early extinguishment of debt	2,037	601
Impairment of long-lived assets, including operating lease assets		1,765
Loss on disposal of equipment and other property	3	2
Deferred income taxes	171	862
Changes in (exclusive of effects of acquisitions):
Trade accounts receivable	(1,054)	4,632
Accounts receivable, other	(10,141)	(5,805)
Inventory	(59,741)	(68,355)
Other current assets	(1,412)	6,053
Other assets	(1,792)	2,201
Operating leases, net	(2,072)	(14,286)
Accounts payable and accrued liabilities	32,314	108
Income taxes payable	(1,842)	434
Other liabilities	(1,516)	(393)
Net cash provided by operating activities	87,960	79,648
Cash Flows from Investing Activities:
Payments for property and equipment, net of proceeds	(44,659)	(42,181)
Acquisitions, net of cash acquired	(218)
Net cash used by investing activities	(44,877)	(42,181)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt	1,056,000	853,000
Repayments of long-term debt	(1,076,054)	(898,093)
Debt issuance costs	(8,332)	(4,726)
Proceeds from equity awards	1,614	1,723
Payments for common stock repurchased	(40,400)
Employee withholding taxes paid related to net share settlement of equity awards	(1,760)	(1,141)
Net cash used by financing activities	(68,932)	(49,237)
Effect of foreign exchange rate changes on cash and cash equivalents	22	2,832
Net decrease in cash and cash equivalents	(25,827)	(8,938)
Cash and cash equivalents, beginning of period	123,001	70,558
Cash and cash equivalents, end of period	97,174	61,620
Supplemental Cash Flow Information:
Interest paid	48,253	35,191
Income taxes paid	32,007	32,077
Capital expenditures incurred but not paid	$ 16,992	$ 5,466

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 29,244	$ 38,390	$ 40,861	$ 50,337	$ 67,634	$ 91,198

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

XML

Significant Accounting Policies

6 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Significant Accounting Policies

1. Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of March 31, 2024, and September 30, 2023, our consolidated results of operations, consolidated comprehensive income and consolidated statements of stockholders’ equity for the three and six months ended March 31, 2024 and 2023, and consolidated cash flows for the six months ended March 31, 2024 and 2023.

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

XML

Recent Accounting Pronouncements

6 Months Ended

Mar. 31, 2024

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

2. Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to enhance segment disclosures for annual and interim consolidated financial statements, including significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”). For public companies, the amendments in the update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but do not expect the update to impact our consolidated results of operations or financial position.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but do not expect the update to impact our consolidated results of operations or financial position.

XML

Revenue Recognition

6 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue Recognition

3. Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

	Six Months Ended March 31,
	2024			2023
Beginning Balance	$	14,038		$	13,460
Loyalty points and gift cards issued but not redeemed, net of estimated breakage		8,700			9,327
Revenue recognized from beginning liability		(9,997	)		(8,370	)
Ending Balance	$	12,741		$	14,417

See Note 11, Segment Reporting, for additional information regarding the disaggregation of our sales revenue.

XML

Fair Value Measurements

6 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

4. Fair Value Measurements

We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date.

The three levels of that hierarchy are defined as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follow:

(in thousands)	Classification	Fair Value Hierarchy Level	March 31, 2024		September 30, 2023
Financial Assets:
Foreign exchange contracts
Non-designated cash flow hedges	Other current assets	Level 2	$	483	$	1,160
Interest rate swap	Other assets	Level 2		2,920		4,668
Total assets			$	3,403	$	5,828
.
Financial Liabilities:
Foreign exchange contracts
Designated cash flow hedges	Accrued liabilities	Level 2	$	1,301	$	—
Non-designated cash flow hedges	Accrued liabilities	Level 2		685		397
Total liabilities			$	1,986	$	397

The fair value of each asset and liability were measured using widely accepted valuation techniques, such as discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

Other fair value disclosures

The carrying amounts of cash equivalents, trade and other accounts receivable, and accounts payable and borrowing under our ABL facility approximate their respective fair values due to the short-term nature of these financial instruments. Carrying amounts and the related estimated fair value of our long-term debt, excluding finance lease obligations, debt issuance costs and original issue discounts, are as follows:

		March 31, 2024				September 30, 2023
(in thousands)	Fair Value Hierarchy Level	Carrying Value		Fair Value		Carrying Value		Fair Value
Long-term debt, excluding finance lease obligations
Senior notes	Level 1	$	600,000	$	593,250	$	679,961	$	662,962
Term loan B due 2030	Level 2		396,000		395,505		398,000		398,000
Total long-term debt		$	996,000	$	988,755	$	1,077,961	$	1,060,962

The fair values of our term loans were measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.

XML

Stockholders' Equity

6 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

5. Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors (“Board”) approved a share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board approved a term extension of our share repurchase program to September 30, 2025. As of March 31, 2024, we had approximately $540.8 million of additional share repurchase authorizations remaining under our share repurchase program. For the three and six months ended March 31, 2024, we repurchased 1.5 million and 3.5 million shares of our common stock at a total cost of $20.0 million and $40.0 million, respectively, excluding the impact of excise taxes. For the three and six months ended March 31, 2023, we did not repurchase shares under our share repurchase program.

Accumulated Other Comprehensive Loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

	Foreign Currency Translation Adjustments			Interest Rate Swap			Foreign Exchange Contracts			Total
Balance at September 30, 2023	$	(124,846	)	$	3,716		$	(1,634	)	$	(122,764	)
Other comprehensive income (loss) before     reclassification, net of tax		7,449			152			(2,042	)		5,559
Reclassification to net earnings, net of tax		—			(1,656	)		2,029			373
Balance at March 31, 2024	$	(117,397	)	$	2,212		$	(1,647	)	$	(116,832	)

The tax impact for the changes in other comprehensive income (loss) and the reclassifications to net earnings was not material.

XML

Weighted-Average Shares

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Weighted-Average Shares

6. Weighted-Average Shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Weighted-average basic shares		104,276		107,453		105,117		107,294
Dilutive securities:
Stock option and stock award programs		2,804		2,253		2,764		2,205
Weighted-average diluted shares		107,080		109,706		107,881		109,499
Anti-dilutive options excluded from our computation of diluted shares		1,733		1,964		1,754		1,964

XML

Goodwill and Intangible Assets

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

7. Goodwill and Intangible Assets

During the three months ended March 31, 2024, we completed our annual assessments for impairment of goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment requiring further quantitative testing. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and intangible assets.

At September 30, 2023, we determined that due to the recent decline in the Company's share price and market capitalization, among other factors, a quantitative assessment was required. Based on our September 30, 2023, quantitative assessment using a discounted cash flow, we estimated the fair value for our BSG reporting unit to be approximately 18% more than its carrying value. The critical assumptions used as part of our evaluation included a projected long-term revenue growth rate of 2.0% and a discount rate of 11.25%, based on a weighted-average cost of capital analysis (adjusted for company specific risk). Our September 30, 2023, quantitative assessment indicated that the fair value of our SBS segment was substantially higher than its carrying value. Goodwill allocated to our SBS and BSG reporting units, which are also defined as our SBS and BSG segment, was $84.9 million and $449.6 million, respectively, as of March 31, 2024.

	Three Months Ended March 31,				Six Months Ended March 31,
(in thousands)	2024		2023		2024		2023
Intangible assets amortization expense	$	791	$	866	$	1,651	$	1,875

For the six months ended March 31, 2024, changes in goodwill reflects the effects of foreign currency exchange rates of $1.8 million and adjustments of $0.4 million from the completion of our Goldwell of NY, Inc. acquisition fair value assessment. Additionally, the changes to other intangibles included effects of foreign currency exchange rates of $0.8 million.

XML

Accrued Liabilities

6 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accrued Liabilities

8. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	March 31, 2024		September 30, 2023
Compensation and benefits	$	63,758	$	69,915
Deferred revenue		17,874		18,259
Rental obligations		10,677		11,266
Insurance reserves		6,931		6,656
Interest payable		4,758		13,447
Property and other taxes		1,379		2,617
Operating accruals and other		44,625		41,206
Total accrued liabilities	$	150,002	$	163,366

XML

Short-term and Long-term Debt

6 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Short-term and Long-term Debt

9. Short-term and Long-term Debt

At March 31, 2024, our ABL facility had $62.0 million in outstanding borrowings and $420.6 million available for borrowing, including the Canadian sub-facility, subject to borrowing base limitation, as reduced by outstanding letters of credit.

On February 12, 2024, we announced a registered public offering of 6.75% senior notes due 2032 (“2032 Senior Notes”). This offering was made pursuant to a shelf registration statement on Form S-3 filed with the SEC on May 10, 2021. On February 27, 2024, we closed on the 2032 Senior Notes and received $594.0 million in cash proceeds net of underwriter fees. The proceeds were used to repay the outstanding $680.0 million principal balance on the 5.625% Senior Notes due 2025 (the “2025 Senior Notes”). The 2032 Senior Notes were issued at par and bear interest at a fixed interest rate of 6.75%. Interest is paid semi-annually during our second and fourth fiscal quarters. The 2032 Senior Notes are guaranteed on a senior secured basis by the guarantors who have guaranteed obligations under our senior secured credit facilities and our existing notes. In connection with the issuance, we incurred approximately $8.8 million in debt issuance costs that is being amortized using the effective interest rate method through the life of the notes.

Additionally on February 12, 2024, we issued a notice to redeem the entire $680.0 million aggregate outstanding principal amount of the 2025 Senior Notes that remained outstanding on March 13, 2024, at a redemption price equal to 100.00% of the principal amount of the 2025 Senior Notes, plus accrued and unpaid interest to, but not including, the redemption date. On March 13, 2024, we redeemed the 2025 Senior Notes with the proceeds of our newly-issued 2032 Senior Notes, cash on hand prior to the new 2032 Senior Notes, and ABL borrowings. In connection with this redemption, we recognized a $2.0 million loss on the extinguishment of debt within interest expense related to unamortized debt issuance costs.

XML

Derivative Instruments and Hedging Activities

6 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

10. Derivative Instruments and Hedging Activities

During the six months ended March 31, 2024, we did not purchase or hold any derivative instruments for trading or speculative purposes. See Note 4, Fair Value Measurements, for the classification and fair value of our derivative instruments.

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At March 31, 2024, we held forwards, which expire ratably through September 30, 2024, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
Mexican Peso	$	11,490
Euro		5,597
Canadian Dollar		5,505
Total	$	22,592

Quarterly, the changes in fair value related to these foreign currency forwards are recorded into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold, based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended March 31, 2024 and 2023, we recognized a loss of $0.6 million and a loss of $0.2 million, respectively. For the six months ended March 31, 2024 and 2023, we recognized a loss of $2.0 million and a gain of $0.1 million, respectively. Based on March 31, 2024, valuations and exchange rates, we expect to reclassify losses of approximately $1.8 million out of AOCL and into cost of goods sold over the next 12 months.

Interest Rate Swap

In April 2023, we entered into a three-year interest rate swap with an initial notional amount of $200 million (the “interest rate swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The interest rate swap involves fixed monthly payments at the contract rate of 3.705%, and in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The interest rate swap will mature in April 2026 and is designated as a cash flow hedge. Changes in the fair value of the interest rate swap are recorded quarterly, net of income tax, and included in AOCL.

For the three and six months ended March 31, 2024, we recognized income of $0.8 million and $1.7 million, respectively, into interest expense on our condensed consolidated statements of earnings related to the interest rate swap. At March 31, 2024, we expect to reclassify gains of approximately $2.4 million out of AOCL and into interest expense over the next 12 months.

Interest Rate Caps

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our prior term loan due 2024. The interest rate caps were comprised of individual caplets and were designated as cash flow hedges. Accordingly, the changes in fair value of the interest rate caps were recorded quarterly, net of income tax, and included in AOCL. During fiscal year 2023, we early settled both interest rate caps due to the forecasted transactions being hedged no longer occurring as a result of the repayment of our prior term loan. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended March 31, 2023. For the six months ended March 31, 2023, we recognized income of $2.8 million into interest expense on our condensed consolidated statements of earnings related to the caps.

Non-Designated Derivative Instruments

We also use foreign exchange contracts to mitigate our exposure to exchange rate changes in connection with certain intercompany balances not permanently invested. At March 31, 2024, we held forwards, which settle on various dates in the first month of the next two fiscal quarters, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
British Pound	$	44,761
Mexican Peso		22,547
Euro		20,928
Canadian Dollar		17,009
Total	$	105,245

We record changes in fair value and realized gains or losses related to these foreign currency forwards into selling, general and administrative expenses. For the three months ended March 31, 2024 and 2023, the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $0.3 million and losses of $1.5 million, respectively. For the six months

ended March 31, 2024 and 2023, the effects of these foreign exchange contracts on our condensed consolidated financial statements were losses of $1.6 million and losses of $1.1 million, respectively.

XML

Segment Reporting

6 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Reporting

11. Segment Reporting

Segment data for the three and six months ended March 31, 2024 and 2023, is as follows (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024			2023
Net sales:
Sally Beauty Supply ("SBS")	$	513,241	$	530,246	$	1,036,479		$	1,079,718
Beauty Systems Group ("BSG")		395,120		388,466		803,184			796,049
Total	$	908,361	$	918,712	$	1,839,663		$	1,875,767
Earnings before provision for income taxes:
Segment operating earnings:
SBS	$	76,820	$	92,134	$	154,449		$	191,308
BSG		43,015		37,260		87,642			86,907
Segment operating earnings		119,835		129,394		242,091			278,215
Unallocated expenses		60,198		50,712		113,416			102,539
Restructuring		63		7,274		(22	)		17,680
Consolidated operating earnings		59,574		71,408		128,697			157,996
Interest expense		20,523		16,685		37,837			34,608
Earnings before provision for income taxes	$	39,051	$	54,723	$	90,860		$	123,388

Sales between segments, which are eliminated in consolidation, were not material during the three and six months ended March 31, 2024 and 2023.

Disaggregation of net sales by segment

Periodically, we make minor adjustments to our product hierarchy, that impacts the roll-up of our merchandise categories. As a result, certain prior year amounts have been reclassified to conform to current year presentation. The following tables disaggregate our segment revenues by merchandise category.

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Hair color		39.6	%		39.8	%		39.2	%		39.2	%
Hair care		25.2	%		24.3	%		24.6	%		23.9	%
Styling tools and supplies		17.0	%		17.9	%		17.6	%		18.7	%
Nail		9.9	%		10.0	%		10.0	%		10.2	%
Skin and cosmetics		7.9	%		7.5	%		8.0	%		7.4	%
Other beauty items		0.4	%		0.5	%		0.6	%		0.6	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Hair care		41.8	%		42.0	%		42.4	%		42.8	%
Hair color		41.5	%		40.6	%		40.4	%		39.4	%
Styling tools and supplies		10.6	%		10.8	%		10.7	%		10.8	%
Skin and cosmetics		3.5	%		3.7	%		3.9	%		4.1	%
Nail		2.3	%		2.7	%		2.4	%		2.7	%
Other beauty items		0.3	%		0.2	%		0.2	%		0.2	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

The following tables disaggregate our segment revenue by sales channels:

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Company-operated stores		93.4	%		93.6	%		93.3	%		93.6	%
E-commerce		6.6	%		6.4	%		6.7	%		6.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Company-operated stores		67.8	%		67.5	%		68.2	%		66.9	%
E-commerce		14.1	%		13.7	%		13.9	%		13.7	%
Distributor sales consultants		10.5	%		11.4	%		10.6	%		12.0	%
Franchise stores		7.6	%		7.4	%		7.3	%		7.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

XML

Restructuring

6 Months Ended

Mar. 31, 2024

Restructuring and Related Activities [Abstract]

Restructuring

12. Restructuring

Restructuring expenses, included in Cost of Goods Sold (“COGS”) and Restructuring for the three and six months ended March 31, 2024 and 2023, are as follows (in thousands):

	Three Months Ended March 31,					Six Months Ended March 31,
	2024		2023			2024			2023
Included in COGS (a)
Distribution Center Consolidation and Store Optimization Plan	$	—	$	(2,362	)	$	—		$	(5,042	)
Included in Restructuring (b)
Distribution Center Consolidation and Store Optimization Plan	$	63	$	7,274		$	(22	)	$	17,680

(a)Amounts included in COGS relate to adjustments to our expected obsolescence reserve related to the Plan (as defined below).

(b)For the three and six months ended March 31, 2023, restructuring consisted of closing costs related to lease terminations and employee termination benefits. The six months ended March 31, 2023, also includes $2.1 million in impairment charges.

Distribution Center Consolidation and Store Optimization Plan

In the fourth quarter of fiscal year 2022, our Board approved the Distribution Center Consolidation and Store Optimization Plan (“the Plan”) authorizing the closure of 330 SBS stores and 35 BSG stores, and the closure of two BSG distribution centers in Clackamas, Oregon and Pottsville, Pennsylvania. Stores identified for early closure were part of a strategic evaluation which included a market analysis of certain locations where we believed we would be able to recapture demand and improve profitability.

The Plan has been substantially completed, as the remaining two BSG stores were closed earlier this fiscal year. However, we may still incur future immaterial charges related to store closures such as exit costs, lease negotiation penalties and adjustments to estimates. As of March 31, 2024, there were no material outstanding liabilities for exit costs or involuntary employee termination benefits.

XML

Significant Accounting Policies (Policies)

6 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of March 31, 2024, and September 30, 2023, our consolidated results of operations, consolidated comprehensive income and consolidated statements of stockholders’ equity for the three and six months ended March 31, 2024 and 2023, and consolidated cash flows for the six months ended March 31, 2024 and 2023.

Principles of Consolidation

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

XML

Revenue Recognition (Tables)

6 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Changes to Contract Liabilities

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

	Six Months Ended March 31,
	2024			2023
Beginning Balance	$	14,038		$	13,460
Loyalty points and gift cards issued but not redeemed, net of estimated breakage		8,700			9,327
Revenue recognized from beginning liability		(9,997	)		(8,370	)
Ending Balance	$	12,741		$	14,417

XML

Fair Value Measurements (Tables)

6 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of financial assets and liabilities and other fair value disclosures by fair value hierarchy

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follow:

(in thousands)	Classification	Fair Value Hierarchy Level	March 31, 2024		September 30, 2023
Financial Assets:
Foreign exchange contracts
Non-designated cash flow hedges	Other current assets	Level 2	$	483	$	1,160
Interest rate swap	Other assets	Level 2		2,920		4,668
Total assets			$	3,403	$	5,828
.
Financial Liabilities:
Foreign exchange contracts
Designated cash flow hedges	Accrued liabilities	Level 2	$	1,301	$	—
Non-designated cash flow hedges	Accrued liabilities	Level 2		685		397
Total liabilities			$	1,986	$	397

Other fair value disclosures

The carrying amounts of cash equivalents, trade and other accounts receivable, and accounts payable and borrowing under our ABL facility approximate their respective fair values due to the short-term nature of these financial instruments. Carrying amounts and the related estimated fair value of our long-term debt, excluding finance lease obligations, debt issuance costs and original issue discounts, are as follows:

		March 31, 2024				September 30, 2023
(in thousands)	Fair Value Hierarchy Level	Carrying Value		Fair Value		Carrying Value		Fair Value
Long-term debt, excluding finance lease obligations
Senior notes	Level 1	$	600,000	$	593,250	$	679,961	$	662,962
Term loan B due 2030	Level 2		396,000		395,505		398,000		398,000
Total long-term debt		$	996,000	$	988,755	$	1,077,961	$	1,060,962

XML

Stockholders' Equity (Tables)

6 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of changes in accumulated other comprehensive loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

	Foreign Currency Translation Adjustments			Interest Rate Swap			Foreign Exchange Contracts			Total
Balance at September 30, 2023	$	(124,846	)	$	3,716		$	(1,634	)	$	(122,764	)
Other comprehensive income (loss) before     reclassification, net of tax		7,449			152			(2,042	)		5,559
Reclassification to net earnings, net of tax		—			(1,656	)		2,029			373
Balance at March 31, 2024	$	(117,397	)	$	2,212		$	(1,647	)	$	(116,832	)

XML

Weighted-Average Shares (Tables)

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of reconciliation of basic and diluted weighted-average shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Weighted-average basic shares		104,276		107,453		105,117		107,294
Dilutive securities:
Stock option and stock award programs		2,804		2,253		2,764		2,205
Weighted-average diluted shares		107,080		109,706		107,881		109,499
Anti-dilutive options excluded from our computation of diluted shares		1,733		1,964		1,754		1,964

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets Amortization Expense

	Three Months Ended March 31,				Six Months Ended March 31,
(in thousands)	2024		2023		2024		2023
Intangible assets amortization expense	$	791	$	866	$	1,651	$	1,875

XML

Accrued Liabilities (Tables)

6 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consist of the following (in thousands):

	March 31, 2024		September 30, 2023
Compensation and benefits	$	63,758	$	69,915
Deferred revenue		17,874		18,259
Rental obligations		10,677		11,266
Insurance reserves		6,931		6,656
Interest payable		4,758		13,447
Property and other taxes		1,379		2,617
Operating accruals and other		44,625		41,206
Total accrued liabilities	$	150,002	$	163,366

XML

Derivative Instruments and Hedging Activities (Tables) - Foreign Exchange Contract

6 Months Ended

Mar. 31, 2024

Schedule of notional amount held through foreign currency forwards, based upon exchange rates

At March 31, 2024, we held forwards, which expire ratably through September 30, 2024, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
Mexican Peso	$	11,490
Euro		5,597
Canadian Dollar		5,505
Total	$	22,592

Non-Designated Derivative Instruments

Schedule of notional amount held through foreign currency forwards, based upon exchange rates

At March 31, 2024, we held forwards, which settle on various dates in the first month of the next two fiscal quarters, with a notional amount, based upon exchange rates at March 31, 2024, as follows (in thousands):

Notional Currency	Notional Amount
British Pound	$	44,761
Mexican Peso		22,547
Euro		20,928
Canadian Dollar		17,009
Total	$	105,245

XML

Segment Reporting (Tables)

6 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of segment data

Segment data for the three and six months ended March 31, 2024 and 2023, is as follows (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024			2023
Net sales:
Sally Beauty Supply ("SBS")	$	513,241	$	530,246	$	1,036,479		$	1,079,718
Beauty Systems Group ("BSG")		395,120		388,466		803,184			796,049
Total	$	908,361	$	918,712	$	1,839,663		$	1,875,767
Earnings before provision for income taxes:
Segment operating earnings:
SBS	$	76,820	$	92,134	$	154,449		$	191,308
BSG		43,015		37,260		87,642			86,907
Segment operating earnings		119,835		129,394		242,091			278,215
Unallocated expenses		60,198		50,712		113,416			102,539
Restructuring		63		7,274		(22	)		17,680
Consolidated operating earnings		59,574		71,408		128,697			157,996
Interest expense		20,523		16,685		37,837			34,608
Earnings before provision for income taxes	$	39,051	$	54,723	$	90,860		$	123,388

Schedule of disaggregation of segment revenues by merchandise category and sales channels

Disaggregation of net sales by segment

Periodically, we make minor adjustments to our product hierarchy, that impacts the roll-up of our merchandise categories. As a result, certain prior year amounts have been reclassified to conform to current year presentation. The following tables disaggregate our segment revenues by merchandise category.

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Hair color		39.6	%		39.8	%		39.2	%		39.2	%
Hair care		25.2	%		24.3	%		24.6	%		23.9	%
Styling tools and supplies		17.0	%		17.9	%		17.6	%		18.7	%
Nail		9.9	%		10.0	%		10.0	%		10.2	%
Skin and cosmetics		7.9	%		7.5	%		8.0	%		7.4	%
Other beauty items		0.4	%		0.5	%		0.6	%		0.6	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Hair care		41.8	%		42.0	%		42.4	%		42.8	%
Hair color		41.5	%		40.6	%		40.4	%		39.4	%
Styling tools and supplies		10.6	%		10.8	%		10.7	%		10.8	%
Skin and cosmetics		3.5	%		3.7	%		3.9	%		4.1	%
Nail		2.3	%		2.7	%		2.4	%		2.7	%
Other beauty items		0.3	%		0.2	%		0.2	%		0.2	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

The following tables disaggregate our segment revenue by sales channels:

	Three Months Ended March 31,						Six Months Ended March 31,
SBS	2024			2023			2024			2023
Company-operated stores		93.4	%		93.6	%		93.3	%		93.6	%
E-commerce		6.6	%		6.4	%		6.7	%		6.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

	Three Months Ended March 31,						Six Months Ended March 31,
BSG	2024			2023			2024			2023
Company-operated stores		67.8	%		67.5	%		68.2	%		66.9	%
E-commerce		14.1	%		13.7	%		13.9	%		13.7	%
Distributor sales consultants		10.5	%		11.4	%		10.6	%		12.0	%
Franchise stores		7.6	%		7.4	%		7.3	%		7.4	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

XML

Restructuring (Tables)

6 Months Ended

Mar. 31, 2024

Restructuring and Related Activities [Abstract]

Summary of restructuring expense and gains

Restructuring expenses, included in Cost of Goods Sold (“COGS”) and Restructuring for the three and six months ended March 31, 2024 and 2023, are as follows (in thousands):

	Three Months Ended March 31,					Six Months Ended March 31,
	2024		2023			2024			2023
Included in COGS (a)
Distribution Center Consolidation and Store Optimization Plan	$	—	$	(2,362	)	$	—		$	(5,042	)
Included in Restructuring (b)
Distribution Center Consolidation and Store Optimization Plan	$	63	$	7,274		$	(22	)	$	17,680

(a)Amounts included in COGS relate to adjustments to our expected obsolescence reserve related to the Plan (as defined below).

(b)For the three and six months ended March 31, 2023, restructuring consisted of closing costs related to lease terminations and employee termination benefits. The six months ended March 31, 2023, also includes $2.1 million in impairment charges.

XML

Revenue Recognition - Schedule of Changes to Contract Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Contract with Customer, Liability [Abstract]
Beginning Balance	$ 14,038	$ 13,460
Loyalty points and gift cards issued but not redeemed, net of estimated breakage	8,700	9,327
Revenue recognized from beginning liability	(9,997)	(8,370)
Ending Balance	$ 12,741	$ 14,417

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Long-term debt, excluding finance lease obligations
Long-term debt, excluding finance lease obligations, Carrying Value	$ 996,000	$ 1,077,961
Long-term debt, excluding finance lease obligations, Fair Value	988,755	1,060,962
Level 1 | Senior notes
Long-term debt, excluding finance lease obligations
Long-term debt, excluding finance lease obligations, Carrying Value	600,000	679,961
Long-term debt, excluding finance lease obligations, Fair Value	593,250	662,962
Level 2 | Term Loan B Due 2030
Long-term debt, excluding finance lease obligations
Long-term debt, excluding finance lease obligations, Carrying Value	396,000	398,000
Long-term debt, excluding finance lease obligations, Fair Value	395,505	398,000
Fair Value, Recurring
Financial Assets:
Total assets	3,403	5,828
Financial Liabilities:
Total liabilities	1,986	397
Fair Value, Recurring | Level 2 | Other current assets | Non-Designated Derivative Instruments
Financial Assets:
Cash flow hedges	483	1,160
Fair Value, Recurring | Level 2 | Other assets
Financial Assets:
Interest rate swap	2,920	4,668
Fair Value, Recurring | Level 2 | Accrued Liabilities | Designated cash flow hedges
Financial Liabilities:
Cash flow hedges	1,301
Fair Value, Recurring | Level 2 | Accrued Liabilities | Non-Designated Derivative Instruments
Financial Liabilities:
Cash flow hedges	$ 685	$ 397

XML

Stockholders' Equity - Share Repurchase Program (Details) - 2017 Share Repurchase program - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Aug. 31, 2017
Share Repurchase Program
Amount of shares authorized to be repurchased		$ 540,800,000		$ 540,800,000		$ 1,000,000,000.0
Stock repurchase program, expiration date	Sep. 30, 2025
Number of shares repurchased		1,500,000	0	3,500,000	0
Total cost of share repurchased		$ 20,000,000		$ 40,000,000

XML

Stockholders' Equity - Change in AOCL (Details) $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($)
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	$ 508,748
Balance	550,850
Interest rate swap
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	3,716
Other comprehensive income (loss) before reclassification, net of tax	152
Reclassification to net earnings, net of tax	(1,656)
Balance	2,212
Foreign exchange contracts
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	(1,634)
Other comprehensive income (loss) before reclassification, net of tax	(2,042)
Reclassification to net earnings, net of tax	2,029
Balance	(1,647)
Foreign currency translation adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	(124,846)
Other comprehensive income (loss) before reclassification, net of tax	7,449
Balance	(117,397)
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income Loss [Line Items]
Balance	(122,764)
Other comprehensive income (loss) before reclassification, net of tax	5,559
Reclassification to net earnings, net of tax	373
Balance	$ (116,832)

XML

Weighted-Average Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share Reconciliation:
Weighted-average basic shares	104,276	107,453	105,117	107,294
Dilutive securities:
Stock option and stock award programs	2,804	2,253	2,764	2,205
Weighted-average diluted shares	107,080	109,706	107,881	109,499
Anti-dilutive options excluded from our computation of diluted shares	1,733	1,964	1,754	1,964

XML

Goodwill and Intangible Assets - (Details) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Sep. 30, 2023
Goodwill [Line Items]
Goodwill	$ 534,494,000	$ 534,494,000	$ 533,081,000
Impairment losses in connection with the goodwill	0
Impairment losses in connection with the intangible assets	0
Goodwill, decreased from effects of foreign currency exchange rates		1,800,000
Intangible assets, decreased from effects of foreign currency exchange rates		800,000
Sally Beauty Supply
Goodwill [Line Items]
Goodwill	84,900,000	84,900,000
Beauty Systems Group
Goodwill [Line Items]
Goodwill	$ 449,600,000	449,600,000
Beauty Systems Group | Discounted Cash Flow
Goodwill [Line Items]
Fair value measurement, percentage			18.00%
Beauty Systems Group | Discounted Cash Flow | Long-term Revenue Growth Rate
Goodwill [Line Items]
Fair value measurement, percentage			2.00%
Beauty Systems Group | Discounted Cash Flow | Discount rate
Goodwill [Line Items]
Fair value measurement, percentage			11.25%
Goldwell
Goodwill [Line Items]
Goodwill adjustment related to acquisitions		$ 400,000

XML

Goodwill and Intangible Assets - Summary of Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets amortization expense	$ 791	$ 866	$ 1,651	$ 1,875

XML

Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Accrued Liabilities
Compensation and benefits	$ 63,758	$ 69,915
Deferred revenue	17,874	18,259
Rental obligations	10,677	11,266
Insurance reserves	6,931	6,656
Interest payable	4,758	13,447
Property and other taxes	1,379	2,617
Operating accruals and other	44,625	41,206
Total accrued liabilities	$ 150,002	$ 163,366

XML

Short-term and Long-term Debt - Additional Information (Details) - USD ($)				6 Months Ended
	Mar. 13, 2024	Feb. 27, 2024	Feb. 12, 2024	Mar. 31, 2024	Mar. 31, 2023
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt				$ 1,056,000,000	$ 853,000,000
Debt instruments issuance cost				8,332,000	4,726,000
Extinguishment of debt				(2,037,000)	$ (601,000)
ABL facility
Debt Instrument [Line Items]
Outstanding borrowing				62,000,000
Revolving credit facility				$ 420,600,000
Senior Notes Due 2032
Debt Instrument [Line Items]
Interest rate		6.75%	6.75%
Proceeds from issuance of long-term debt		$ 594,000,000
Debt, interest rate terms				Interest is paid semi-annually during our second and fourth fiscal quarters.
Debt issuance costs		$ 8,800,000
Senior Notes Due 2025
Debt Instrument [Line Items]
Aggregate principal amount			$ 680,000,000
Interest rate		5.625%
Debt instrument, redemption price, percentage			100.00%
Repayments of outstanding principal balance of senior debt		$ 680,000,000
Extinguishment of debt	$ (2,000,000)

XML

Derivative Instruments and Hedging Activities - (Details)	1 Months Ended	3 Months Ended		6 Months Ended
	Apr. 30, 2023 USD ($)	Mar. 31, 2024 USD ($) Instrument	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($) Instrument	Mar. 31, 2023 USD ($)	Jul. 31, 2017 USD ($) Derivative
Derivative Instruments
Number of derivative instruments held | Instrument		0		0
Interest expense		$ 20,523,000	$ 16,685,000	$ 37,837,000	$ 34,608,000
Foreign Currency Forwards | Selling, General and Administrative Expenses
Derivative Instruments
Foreign currency forwards designated as cash flow hedges to be reclassified in to cost of goods sold		(300,000)	(1,500,000)	(1,600,000)	(1,100,000)
Foreign Currency Forwards | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments
Foreign currency forwards designated as cash flow hedges to be reclassified in to cost of goods sold		(600,000)	$ (200,000)	(2,000,000)	100,000
Foreign currency forwards designated as cash flow hedges to be reclassified losses into cost of goods sold over next 12 months		1,800,000		1,800,000
Interest Rate Caps | Variable-rate tranche | Sally Holdings, LLC
Derivative Instruments
Notional Amount						$ 550,000,000
Number of interest rate caps | Derivative						2
Interest income					$ 2,800,000
Interest Rate Swap | Sally Holdings, LLC
Derivative Instruments
Derivative instruments, expiration date	Apr. 30, 2026
Term of derivative instrument	3 years
Notional Amount	$ 200,000,000
Fixed interest rate	3.705%
Interest income		800,000		1,700,000
Interest rate caps designated as cash flow hedges to be reclassified into interest expense over next 12 months		$ 2,400,000		$ 2,400,000

XML

Derivative Instruments and Hedging Activities - Schedule of Notional Amount Held Through Foreign Currency Forwards, Based Upon Exchange Rates (Details)	Mar. 31, 2024 USD ($)
Foreign Currency Forwards | Designated cash flow hedges
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	$ 22,592,000
Foreign Currency Forwards | Non-Designated Derivative Instruments
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	105,245,000
British Pound | Non-Designated Derivative Instruments
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	44,761,000
Mexican Peso | Designated cash flow hedges
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	11,490,000
Mexican Peso | Non-Designated Derivative Instruments
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	22,547,000
Euro | Designated cash flow hedges
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	5,597,000
Euro | Non-Designated Derivative Instruments
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	20,928,000
Canadian Dollar | Designated cash flow hedges
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	5,505,000
Canadian Dollar | Non-Designated Derivative Instruments
Foreign Currency Fair Value Hedge Derivative [Line Items]
Notional Amount	$ 17,009,000

XML

Segment Reporting (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Net sales:
Total net sales	$ 908,361	$ 918,712	$ 1,839,663	$ 1,875,767
Segment operating earnings:
Segment operating earnings	59,574	71,408	128,697	157,996
Restructuring	63	7,274	(22)	17,680
Interest expense	20,523	16,685	37,837	34,608
Earnings before provision for income taxes	39,051	54,723	90,860	123,388
Operating segments
Segment operating earnings:
Segment operating earnings	119,835	129,394	242,091	278,215
Corporate
Segment operating earnings:
Unallocated expenses	60,198	50,712	113,416	102,539
Sally Beauty Supply
Net sales:
Total net sales	513,241	530,246	1,036,479	1,079,718
Sally Beauty Supply | Operating segments
Segment operating earnings:
Segment operating earnings	76,820	92,134	154,449	191,308
Beauty Systems Group
Net sales:
Total net sales	395,120	388,466	803,184	796,049
Beauty Systems Group | Operating segments
Segment operating earnings:
Segment operating earnings	$ 43,015	$ 37,260	$ 87,642	$ 86,907

XML

Segment Reporting - Schedule of Disaggregation of Net Sales by Segment (Details) - Sales Revenue, Net - Product Concentration Risk	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Sally Beauty Supply
Disaggregation Of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
Sally Beauty Supply | Hair color
Disaggregation Of Revenue [Line Items]
Percentage of net sales	39.60%	39.80%	39.20%	39.20%
Sally Beauty Supply | Hair care
Disaggregation Of Revenue [Line Items]
Percentage of net sales	25.20%	24.30%	24.60%	23.90%
Sally Beauty Supply | Styling tools and supplies
Disaggregation Of Revenue [Line Items]
Percentage of net sales	17.00%	17.90%	17.60%	18.70%
Sally Beauty Supply | Nail
Disaggregation Of Revenue [Line Items]
Percentage of net sales	9.90%	10.00%	10.00%	10.20%
Sally Beauty Supply | Skin and cosmetics
Disaggregation Of Revenue [Line Items]
Percentage of net sales	7.90%	7.50%	8.00%	7.40%
Sally Beauty Supply | Other Beauty items
Disaggregation Of Revenue [Line Items]
Percentage of net sales	0.40%	0.50%	0.60%	0.60%
Sally Beauty Supply | Sales channel, directly to consumer | Company-operated stores
Disaggregation Of Revenue [Line Items]
Percentage of net sales	93.40%	93.60%	93.30%	93.60%
Sally Beauty Supply | Sales channel, through intermediary | E-commerce
Disaggregation Of Revenue [Line Items]
Percentage of net sales	6.60%	6.40%	6.70%	6.40%
Beauty Systems Group
Disaggregation Of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
Beauty Systems Group | Hair color
Disaggregation Of Revenue [Line Items]
Percentage of net sales	41.50%	40.60%	40.40%	39.40%
Beauty Systems Group | Hair care
Disaggregation Of Revenue [Line Items]
Percentage of net sales	41.80%	42.00%	42.40%	42.80%
Beauty Systems Group | Styling tools and supplies
Disaggregation Of Revenue [Line Items]
Percentage of net sales	10.60%	10.80%	10.70%	10.80%
Beauty Systems Group | Nail
Disaggregation Of Revenue [Line Items]
Percentage of net sales	2.30%	2.70%	2.40%	2.70%
Beauty Systems Group | Skin and cosmetics
Disaggregation Of Revenue [Line Items]
Percentage of net sales	3.50%	3.70%	3.90%	4.10%
Beauty Systems Group | Other Beauty items
Disaggregation Of Revenue [Line Items]
Percentage of net sales	0.30%	0.20%	0.20%	0.20%
Beauty Systems Group | Sales channel, directly to consumer | Company-operated stores
Disaggregation Of Revenue [Line Items]
Percentage of net sales	67.80%	67.50%	68.20%	66.90%
Beauty Systems Group | Sales channel, through intermediary | Distributor sales consultants
Disaggregation Of Revenue [Line Items]
Percentage of net sales	10.50%	11.40%	10.60%	12.00%
Beauty Systems Group | Sales channel, through intermediary | E-commerce
Disaggregation Of Revenue [Line Items]
Percentage of net sales	14.10%	13.70%	13.90%	13.70%
Beauty Systems Group | Sales channel, through intermediary | Franchise stores
Disaggregation Of Revenue [Line Items]
Percentage of net sales	7.60%	7.40%	7.30%	7.40%

XML

Restructuring - Summary of Restructuring Expense and Gains (Details) - Distribution Center Consolidation and Store Optimization Plan - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Restructuring Cost And Reserve [Line Items]
Total in COGS		$ (2,362)		$ (5,042)
Total in Restructuring	$ 63	$ 7,274	$ (22)	$ 17,680

XML

Restructuring - Summary of Restructuring Expense and Gains (Parenthetical) (Details) $ in Millions	6 Months Ended
	Mar. 31, 2024 USD ($)
Distribution Center Consolidation and Store Optimization Plan
Restructuring Cost and Reserve [Line Items]
Impairment charges related to restructuring	$ 2.1